Dose-Dependent Augmentation of Neuroplasticity-Based Auditory Learning in Schizophrenia: A Double-Blind, Placebo-Controlled, Randomized, Target Engagement Clinical Trial of the NMDA Glutamate Receptor Agonist d-serine
Pejman Sehatpour, Dan V. Iosifescu, Heloise M. De Baun, Constance Shope, Megan Mayer, James E. Gangwisch, Elisa C. Dias, Tarek Sobeih, Tse‐Hwei Choo, Melanie M. Wall, Alice Medalia, Alice M. Saperstein, Lawrence S. Kegeles, Ragy R. Girgis, Marlene Carlson, Joshua T. Kantrowitz
Topics & Concepts
NMDA receptorNeuroplasticityAgonistSchizophrenia (object-oriented programming)Glutamate receptorPlaceboNeurosciencePsychologyMedicineAnesthesiaPharmacologyReceptorPsychiatryInternal medicineAlternative medicinePathologyAmino Acid Enzymes and MetabolismNeuroscience and Neuropharmacology ResearchNeuroscience and Music Perception